Nationwide, COVID-19 cases have increased 54 percent and hospitalization by 19 percent over the last 14 days as of May 5, according to HHS data tracked by The New York Times.
The collective sense of what constitutes a spike changed after the omicron surge this winter, referred to as a “new normal” by Maia Majumder, PhD, an infectious-disease modeler at Harvard Medical School and Boston Children’s Hospital.
Perspective isn’t the only issue, according to Ms. Wu. The underestimation of cases is also contributing to the lax attitude about current numbers, she said. The country’s goals have shifted with new CDC guidance, but the number of cases are about the same as they were in July during the delta surge, Ms. Wu wrote.
“The goal now should be to look at what’s ahead,” Ms. Wu wrote. “It hardly matters if Americans end up calling this case rise, or future ones, a wave or wavelet, a surge or swell, so long as they take stock of whatever this is and try to keep it from growing even more.”
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
